LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Extracellular Collagen Modulates Tumor Progression and Metastasis

By LabMedica International staff writers
Posted on 05 Dec 2017
Image: Breast cancer cells were grown in a highly dense three-dimensional collagen matrix. After seven days the cells formed networks that resembled the early stages of blood vessel development. This photomicrograph shows representative structures observed in these environments after staining for cell nuclei (blue) and cytoskeletons (green) (Photo courtesy of the University of California, San Diego).
Image: Breast cancer cells were grown in a highly dense three-dimensional collagen matrix. After seven days the cells formed networks that resembled the early stages of blood vessel development. This photomicrograph shows representative structures observed in these environments after staining for cell nuclei (blue) and cytoskeletons (green) (Photo courtesy of the University of California, San Diego).
A recent paper detailed how factors in the tumor microenvironment induce the cancer to progress and metastasize.

Previous studies had suggested that the topographical organization of collagen within the tumor microenvironment modulated cancer cell migration and was independently predictive of progression to metastasis.

Investigators at the University of California, San Diego (USA) explored the relationships between collagen density, collagen architecture, cell migration behavior, gene expression, and metastatic potential. To do this, they developed a three-dimensional collagen matrix model system designed to probe the physical basis of cancer cell migration responses to collagen matrix organization.

Results published in the November 21, 2017, online edition of the journal Nature Communications revealed that collagen matrices with small pores and short fibers conserved a transcriptional response and subsequent motility switch in cancer cells resulting in the formation of multicellular network structures. The response was not mediated by hypoxia, matrix stiffness, or bulk matrix density, but rather by matrix architecture-induced beta1-integrin upregulation. The set of genes, or gene module, which caused this behavior, was dubbed the collagen-induced network phenotype (CINP).

The investigators found that this CINP-induced behavior was consistent with phenotypic and molecular features of clinical vasculogenic mimicry (VM) – the formation of structures resembling blood vessels. Furthermore, they showed that the associated transcriptional response was conserved among cancer types in vitro and was predictive of patient survival in multiple clinical datasets for various tumor types. These findings linked a collagen-induced migration program to VM and suggested that this process could be broadly relevant to metastatic progression in solid human cancers.

"It is almost like the matrix is encoding the gene module," explained senior author Dr. Stephanie Fraley, professor of bioengineering at the University of California, San Diego. "The cells do not exhibit this behavior in traditional petri dishes. It is critical to have the cells surrounded by a three-dimensional environment that mimics what happens in the human body."

Related Links:
University of California, San Diego

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more